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Abstract: Methionine aminopeptidases (MetAPs) represent a unique class of 
protease that is capable of the hydrolytic removal of an N-terminal 
methionine residue from nascent polypeptide chains. MetAPs are 
physiologically important enzymes; hence, there is considerable interest in 
developing inhibitors that can be used as anti-angiogenic and antimicrobial 
agents. A detailed kinetic and spectroscopic study has been performed to 
probe the binding of a triazole-based inhibitor and a bestatin-based inhibitor 
to both Mn(II)- and Co(II)-loaded type-I (Escherichia coli) and type-II 
(Pyrococcus furiosus) MetAPs. Both inhibitors were found to be moderate 
competitive inhibitors. The triazole-type inhibitor was found to interact with 
both active-site metal ions, while the bestatin-type inhibitor was capable of 
switching its mode of binding depending on the metal in the active site and 
the type of MetAP enzyme. 
Keywords: Hydrolysis, Manganese, Electron paramagnetic resonance, 
Antibiotics, Electronic absorption 
Introduction 
Methionine aminopeptidases (MetAPs) represent a unique class 
of metalloprotease that is responsible for removing N-terminal 
methionine residues from polypeptide chains.1,2 On the basis of 
fumagillin affinity chromatography and mass spectrometry, MetAPs 
were identified as the molecular targets of ovalicin, fumagillin, and 
TNP-470.3 The activity of this sesquiterpiene epoxide containing 
molecule has been evaluated for the treatment of a variety of cancers 
such as Kaposi's sarcoma, cervical cancer, brain cancer, and renal cell 
carcinoma.4 Furthermore, in vivo studies showed that one of the 
observed effects of the inhibition of MetAPs by antiangiogenesis agents 
is the failure to expose glycine residues at the N termini of certain 
signaling proteins involved in cell cycle regulation, preventing 
myristolyation.5 Selective inhibition of tumor cells by targeting a 
common molecule required for signal transduction of numerous growth 
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stimulators provides an effective approach to treat cancer.6-10 MetAPs 
represent just such a target and, therefore, understanding the 
catalytic mechanism of MetAPs is critically important for the future 
development of drugs that prevent tumor vasculature formation, 
growth, and proliferation.11-14 In addition, sesquiterpiene epoxide 
containing molecules have been shown to inhibit the in vitro growth of 
the malaria parasites Plasmodium falciparum and Leishmania 
donavani; therefore, drug design efforts that target MetAPs may have 
additional applications in the treatment of malaria and leishmaniasis.15 
MetAPs are organized into two classes (types I and II) on the 
basis of the absence or presence of an extra 62 amino acid sequence 
(of unknown function) inserted near the catalytic domain. The type-I 
MetAPs from Escherichia coli (EcMetAP-I), Staphylococcus aureus, 
Thermotoga maritime, and Homo sapiens and the type-II MetAPs from 
H. sapiens (HsMetAP-II) and Pyrococcus furiosus (PfMetAP-II) have 
been crystallographically characterized.16-21 All six display a novel 
“pita-bread” fold with an internal pseudo twofold symmetry that 
structurally relates the first and second halves of the polypeptide chain 
to each other. Both domains contribute conserved residues to the 
metallo-active site. In all six structures, a bis(μ-carboxylato)(μ-
aquo/hydroxo)dicobalt core is observed with an additional carboxylate 
residue at each metal site and a single histidine bound to Co1. An X-
ray crystal structure of EcMetAP-I was recently reported with partial 
occupancy (40%) of a single Mn(II) ion bound in the active site.22 This 
structure was obtained by adding the transition-state analog inhibitor 
l-norleucine phosphonate, to impede divalent metal binding to the 
second site, and by limiting the amount of metal ion present during 
crystal growth. This structure provides the first structural verification 
that MetAPs can form mononuclear active sites and the single divalent 
metal ion resides on the H171 side of the active site as previously 
predicted by 1H NMR and extended X-ray absorption fine structure 
spectroscopy.23,24 
A current challenge facing the rational design of highly potent 
inhibitors of MetAPs is that some candidate compounds fail to have 
similar efficacy between in vitro and in vivo experiments.25 Such 
differences between in vivo and in vitro effectiveness have been 
partially ascribed to the lack of certainty about the identity of the in 
vivo metal ion for MetAPs and its stoichiometry.25,26 The dissimilarity in 
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metal identity and its occupancy number within the active site may 
have subtle effects on the catalytic mechanism of MetAPs, which 
manifests itself in significant differences in the efficacy of potential 
inhibitors. It has been established that MetAPs can be activated by 
Co(II), Fe(II), and Mn(II), but that Zn(II) will not activate either type-
I or type-II enzymes.23,26-28 However, a single study on the type-I 
MetAP from Saccharomyces cerevisiae suggested that Zn(II) ions, in 
the presence of 5 mM glutathione and 2 mM EDTA under aerobic 
conditions, provided an active MetAP enzyme, while the Co(II)-
containing enzyme was largely inactivated under similar conditions and 
no activity could be observed in the presence of Fe(II).29 Even more 
recently, the physiologically relevant metal ion for HsMetAP-II was 
shown to be Mn(II) using Co(II)-specific synthetic inhibitors to probe 
intracellular HsMetAP-II (Fig. 1).25 To understand the mechanism of 
inhibitor binding to MetAP and to determine why a triazole-containing 
inhibitor, 3-((2-naphthylmethyl)sulfanyl)-4H-1,2,4-triazole (A-
310840), strongly inhibits Co(II)-loaded HsMetAP-II but not Mn(II)-
loaded HsMetAP-II, while a bestatin-like inhibitor, ((2RS,3R)-3-amino-
2-hydroxy-5-ethylthio)pentanoyl-((S)-(−)-(1-naphthyl)ethyl)amide (A-
311263), inhibits each metal-substituted HsMetAP-II enzyme equally 
well, we have investigated the binding affinities and structural aspects 
of each of these inhibitor interactions with EcMetAP-I and PfMetAP-II. 
 
Fig. 1. Molecular structures of the triazole-like (A310840) and the bestatin-like 
(A311263) methionine aminopeptidase (MetAP) inhibitors 
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Materials and methods 
Purification of MetAP enzymes 
All chemicals used in this study were purchased commercially and 
were of the highest quality available. Recombinant EcMetAP-I was 
expressed and purified as previously described.23,27,28 Purified 
EcMetAP-I exhibited a single band on sodium dodecyl sulfate 
polyacrylamide gel electrophoresis. Protein concentrations were 
obtained spectrophotometrically at 280 nm using an extinction 
coefficient ε280 nm of 16,445 M−1 cm−1. Apo-EcMetAP-I was washed free 
of methionine using Chelex-100-treated methionine-free buffer [25 
mM N-(2-hydroxyethyl)piperazine-N′-ethanesulfonic acid (HEPES), pH 
7.5, 150 mM KCl] and concentrated by microfiltration using a 
Centricon-10 (Amicon, Beverly, MA, USA) prior to all kinetic assays. 
Individual aliquots of apo-EcMetAP-I were routinely stored at −80 °C 
or in liquid nitrogen until needed. 
PfMetAP-II was purified as previously reported and exhibited a 
single band on sodium dodecyl sulfate polyacrylamide gel 
electrophoresis.28 Protein concentrations were estimated from the 
absorbance at 280 nm using an extinction coefficient ε280 nm of 21,650 
M−1 cm−1. Metal-free PfMetAP-II was prepared by concentrating 
purified PfMetAP-II to a volume of approximately 5 mL, after which 
EDTA was added to a final concentration of 10 mM. The resulting 
protein solution was dialyzed against 25 mM HEPES buffer (2 L, pH 
7.5) containing 10 mM EDTA and 150 mM KCl at 4 °C for 2 days with 
two buffer changes per day. The protein solution was then dialyzed 
against Chelex-100-treated 25 mM HEPES buffer (2 L, pH 7.5) 
containing 150 mM KCl for 3 days against two buffer changes per day. 
The resulting PfMetAP-II was inactive and found to contain no 
detectable metal ions via inductively coupled plasma atomic emission 
spectrometry. This enzyme, deemed “apo-PfMetAP-II,” was stored at 
−80 °C until needed. 
Synthesis of the triazole MetAP inhibitor A-310840 
The inhibitor A-310840 was synthesized as previously 
described.25 Briefly, to a suspension of 3-mercapto-1,2,4-triazole (0.18 
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g, 1.8 mmol) and cesium carbonate (0.72 g, 2.2 mmol) in 5 mL of 
N,N-dimethylformamide was added 2-(bromomethyl)naphthalene 
(0.38 g, 1.7 mmol). The mixture was heated at 40 °C for 16 h. The 
volume was reduced by rotary evaporation, and the remaining mixture 
was shaken with water and methylene chloride and then filtered. The 
layers of the filtrate were separated, and the organic phase was dried 
over magnesium sulfate. Filtration and solvent removal gave a white 
solid (0.143 g). Mass spectrometry (desorption chemical 
ionization/NH3) m/z 242 (M + H)+, 259 (M + NH4)+; 1H NMR (300 MHz, 
dimethyl-d6 sulfoxide, δ) 14.08 (s, 1H), 8.57 (bds, 1H), 7.88 (m, 4H), 
7.49 (m, 3H), 4.51 (s, 2H); Anal. Calcd for C10H2ON4S: C, 64.70; H, 
4.59; N, 17.41. Found: C, 64.93; H, 4.58; N, 17.25. 
Synthesis of the bestatin MetAP inhibitor A-311263 
The inhibitor A-311263 was synthesized as previously described 
from d-methionine (Aldrich Chemical Co.).25 Mass spectrometry 
(electrospray ionization + quadrupole 1 MS) m/z 347 (M + H)+, 693 (2 
M + H)+; 1H NMR (300 MHz, dimethyl-d6 sulfoxide, δ) 8.75−7.47 (m, 
7H), 6.55 (br, 1H), 4.82−4.75 (m, 1H), 4.15 (d, 1H), 3.60−3.33 (br 
m, 3H), 2.68−2.34 (m, 3.6H), 2.18 (q, 0.4H), 1.87−1.68 (m, 2H), 
1.58−1.53 (m, 3H), 1.13 (t, 0.6H), 0.98 (t, 0.4H). Anal. Calcd for 
C19H27N2O2S·HCl: C, 59.59; H, 7.11; N, 7.32. Found: C, 59.54; H, 
7.13; N, 7.16. 
Enzymatic assay of MetAPs 
All enzymatic assays were performed under strict anaerobic 
conditions in an inert atmosphere glove box (Coy) with a dry bath 
incubator to maintain the temperature. Catalytic activities were 
determined with an error of ±5%. Enzyme activities for both EcMetAP-
I and PfMetAP-II were determined in 25 mM HEPES buffer, pH 7.5, 
containing 150 mM KCl with the tetrapeptide substrate MGMM. The 
amount of product formation was determined by high-performance 
liquid chromatography (HPLC; Shimadzu LC-10A class-VP5). A typical 
assay involved the addition of 4 μL of metal-loaded MetAP to a 16 μL 
substrate–buffer mixture at 30 °C for 1 min. The reaction was 
quenched by the addition of 20 μL of 1% trifluoroacetic acid solution. 
Elution of the product was monitored at 215 nm following separation 
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on a C8 HPLC column (Phenomenex, Luna; 5 μm, 4.6 cm × 25 cm), as 
previously described.23,27,28 Enzyme activities are expressed as units 
per milligram, where one unit is defined as the amount of enzyme that 
releases 1 μmol of product in 1 min at 30 °C. Inhibition studies were 
performed by the addition of either A-310840 or A-311263 at a 
concentration of 0.1−2,000 μM to the assay using a substrate 
concentration of 8 mM. 
Isothermal titration calorimetry 
Isothermal titration calorimetry (ITC) measurements were 
carried out with a MicroCal OMEGA ultrasensitive titration calorimeter. 
The titrants (A-310840 and A-311263) and apo-MetAP solutions were 
prepared in Chelex-100-treated HEPES buffer at pH 7.5. Stock buffer 
solutions were thoroughly degassed before each titration. The enzyme 
solution (50−80 μM) loaded with 2 equiv of metal ions [Co(II) or 
Mn(II)] was placed in the calorimeter cell and stirred at 200 rpm to 
ensure rapid mixing. Typically, 4−10 μL of titrant was delivered over 
7.6 s with a 6-min interval between injections to allow for complete 
equilibration. Each titration was continued until 4.5−6 equiv of 
inhibitor had been added to ensure that no additional complexes were 
formed in excess titrant. A background titration, consisting of the 
identical titrant solution but only the buffer solution in the sample cell, 
was subtracted from each experimental titration to account for heat of 
dilution. The data were analyzed with a one- or two-site binding model 
by the Windows-based Origin software package supplied by MicroCal.30 
Spectroscopic measurements 
Electronic absorption spectra were recorded using a Shimadzu 
UV-3101PC spectrophotometer. All apo-MetAP samples used in 
spectroscopic measurements were made rigorously anaerobic prior to 
incubation with Co(II) (CoCl2 99.999% or better purity; Strem 
Chemicals, Newburyport, MA, USA) for approximately 30 min at 25 °C. 
All Co(II)-containing samples were handled throughout in an anaerobic 
glove box (Ar/5% H2, 1 ppm or less O2; Coy Laboratories) until frozen. 
Electronic absorption spectra were normalized for the protein 
concentration and the absorption due to uncomplexed Co(II) (ε512 nm = 
6.0 M−1 cm−1).23 Low-temperature EPR spectroscopy was performed 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Journal of Biological Inorganic Chemistry, Vol 14, No. 4 (May 2009): pg. 573-585. DOI. This article is © Springer and 
permission has been granted for this version to appear in e-Publications@Marquette. Springer does not grant permission 
for this article to be further copied/distributed or hosted elsewhere without the express permission from Springer. 
8 
 
using either a Bruker ESP-300E or a Bruker EleXsys E600 
spectrometer, each equipped with an ER 4116 DM dual-mode X-band 
cavity operating at 9.63 GHz (B0⊥B1) or 9.37 GHz (B0∥B1) and an 
Oxford Instruments ESR-900 helium-flow cryostat. All spectra were 
recorded using 100-kHz magnetic field modulation. Other EPR running 
parameters are specified in the figure legends for individual samples. 
EPR simulations were carried out using matrix diagonalization 
(XSophe, Bruker Biospin), assuming a spin Hamiltonian H = βgHS + 
SDS + SAI, with S = 3/2 and D >> βgHS (=hν). Enzyme 
concentrations for EPR were 1 mM. 
Results 
Determination of IC50 values 
Data on inhibition of MetAP activity by A-311263 and A-310840 
(IC50 values) towards the Co(II)- and Mn(II)-loaded PfMetAP-II and 
EcMetAP-I enzymes are provided in Table 1. A-310840, a triazole-
containing inhibitor, binds potently to PfMetAP-II in the presence of 
Co(II) (IC50 of 15 μM) but is approximately 67-fold less potent for 
Mn(II)-loaded PfMetAP-II (IC50 of 1,000 μM). A similar trend is 
observed for EcMetAP-I, except that A-310840 binds to the Co(II)-
loaded enzyme well (IC50 of 44 μM) but is approximately 23-fold less 
potent for Mn(II)-loaded EcMetAP-I (IC50 of 1,000 μM). In comparison, 
the bestatin-type inhibitor, A-311263, has little or no preference for 
the type of divalent metal ion that occupies the active site. A-311263 
also inhibits PfMetAP-II and EcMetAP-I loaded with either Co(II) or 
Mn(II) similarly, with IC50 values between 20 and 34 μM. 
Table 1. IC50, inhibition constants (Ki), dissociation constants (Kd), 
stoichiometry (n), and thermodynamics parameters for 3-((2-
naphthylmethyl)sulfanyl)-4H-1,2,4-triazole (A-310840) and ((2RS,3R)-3-
amino-2-hydroxy-5-ethylthio)pentanoyl-((S)-(−)-(1-naphthyl)ethyl) amide 
(A-311263) binding to Co(II)- and Mn(II)-loaded type-II methionine 
aminopeptidase (MetAP) from Pyrococcus furiosus (PfMetAP-II) and type-I 
MetAP from Escherichia coli (EcMetAP-I) 
 
Wild-type enzymes n IC50 
(μM) 
Ki 
(μM) 
Kd (μM) ΔH 
(kJ/mol) 
TΔS 
(J/mol) 
ΔG (kJ/mol) 
A-310840 binding to wild-type enzymes 
[CoCo(PfMetAP-II)] 1 15 3 2.0 ± 0.1 −5.5 ± 2 27 × 103 −32.5 
[MnMn(PfMetAP-II)] 1 1,000 440 666 ± 10 −0.3 ± 0.1 17 × 103 −18.1 
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Wild-type enzymes n IC50 
(μM) 
Ki 
(μM) 
Kd (μM) ΔH 
(kJ/mol) 
TΔS 
(J/mol) 
ΔG (kJ/mol) 
[CoCo(EcMetAP-I)] 1 44 8 10 ± 0.1 8.36 ± 0.3 20 × 103 −28.5 
[MnMn(EcMetAP-I)] 1 1,000 750 714 ± 10 −24.6 ± 3 −7 × 103 −17.9 
A-311263 binding to wild-type enzymes 
[CoCo(PfMetAP-II)] 1 20 2 0.45 ± 
0.11 
−14.9 ± 2 21 × 103 −36.2 
[MnMn(PfMetAP-II)] 1 27 20 26 ± 5 −62.7 ± 5 −36 × 103 −26.1 
[CoCo(EcMetAP-I)] 1 32 3 2.4 ± 0.1 1.57 ± 0.3 33 × 103 −32 
[MnMn(EcMetAP-I)] 1 34 20 50 ± 5 −19 ± 4 6 × 103 −24.5 
 
Kinetic determination of Ki values 
Previous work indicated that A-310840 and A-311263 are strong 
inhibitors of HsMetAP-II on the basis of IC50 values.25 We have 
carefully examined the hydrolysis of the tetrapeptide substrate MGMM 
by both PfMetAP-II and EcMetAP-I in the presence of various 
concentrations of A-310840 and A-311263. Ki values for A-310840 and 
A-311263 binding to PfMetAP-II and EcMetAP-I were obtained by 
fitting the kinetic data to the Michaelis–Menten equation for 
competitive inhibition (Table 1). A-310840 is a much more potent 
competitive inhibitor towards Co(II)-loaded PfMetAP-II (Ki = 3 μM) and 
EcMetAP-I (Ki = 8 μM) compared with the Mn(II)-loaded PfMetAP-II (Ki 
= 440 μM) and EcMetAP-I (Ki = 750 μM) enzymes. On the other hand, 
A-311263 inhibits Co(II)-loaded PfMetAP-II (Ki = 2 μM) and EcMetAP-I 
(Ki = 3 μM) by a magnitude similar to that of Mn(II)-loaded PfMetAP-II 
(Ki = 27 μM) and EcMetAP-I (Ki = 34 μM). 
Isothermal titration calorimetry 
The use of ITC to measure the binding of exogenous ligands to 
biomolecules relies on the fact that such an interaction is accompanied 
by a heat effect. The heat absorbed (endothermic) or released 
(exothermic) upon inhibitor–enzyme interaction is used to obtain the 
dissociation constant, Kd, and the enthalpy of binding, ΔH. ITC 
measurements for the binding of A-310840 and A-311263 to Co(II)- 
and Mn(II)-loaded EcMetAP-I and PfMetAP-II were carried out with a 
MicroCal OMEGA ultrasensitive titration calorimeter at 25.0 ± 0.2 °C. 
Kd values were obtained by fitting these data, after subtraction of the 
background heat of dilution, via an interactive process using the Origin 
software package. This software package uses a nonlinear least-
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squares algorithm, which allows the concentrations of the titrant and 
the sample to be fit to the heat flow per injection, to an equilibrium 
binding equation for either one site or two noninteracting sites. The Ka 
value, the enzyme–metal stoichiometry (n), and the change in 
enthalpy (ΔH) were allowed to vary during the fitting process. The 
relationship between Ka and the dissociation constant is defined as Kd 
= 1/Ka. The best fits obtained for the binding of A-310840 to Co(II)-
loaded PfMetAP-II and EcMetAP-I provided an overall n value of 1 and 
Kd values of 2.0 and 10 μM, respectively, which indicate approximately 
333-fold and approximately 71-fold stronger binding than is observed 
for A-310840 binding to Mn(II)-loaded PfMetAP-II (Kd = 666 μM) and 
EcMetAP-I (Kd = 714 μM). On the other hand, the best fits obtained for 
the binding of A-311263 to Co(II)-loaded PfMetAP-II and EcMetAP-I 
provided an overall n value of 1 and Kd values of 0.45 and 2.4 μM, 
respectively. These values indicate approximately 58-fold and 
approximately 21-fold tighter binding than is observed for Mn(II)-
loaded PfMetAP-II and EcMetAP-I, respectively (Table 1). 
The heat of reaction, ΔH, measured during an ITC experiment 
was converted into other thermodynamic parameters using the Gibbs 
free energy relationship:  
DG0⦁⦁RTlnKa⦁DH0⦁TDS0 
2 
The thermodynamic parameters for the binding of A-310840 and 
A-311263 to Co(II)- and Mn(II)-loaded PfMetAP-II and EcMetAP-I are 
listed in Table 1. Binding of these inhibitors to both type-I and type-II 
MetAPs was found to be spontaneous on the basis of the observed 
negative Gibbs free energy (ΔG). In general, the ΔG values for the 
binding of both inhibitors to PfMetAP-II are slightly more negative than 
the ΔG values obtained for EcMetAP-I. The energy change associated 
with Co(II)-loaded EcMetAP-I with A-311263 is weakly endothermic, 
with a ΔH value of 1.57 kJ mol−1, while in other cases ΔH was found to 
be weakly exothermic, with values ranging between −0.3 and −63 kJ 
mol−1. It is noteworthy that the entropic factor (TΔS) for the binding of 
each inhibitor to PfMetAP-II and EcMetAP-I varies depending on the 
enzyme and metal ions present. For example, the TΔS values for the 
binding of A-310840 to Mn(II)-loaded EcMetAP-I and the binding of A-
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311263 to Mn(II)-loaded PfMetAP-II are negative, whereas in all other 
cases the observed TΔS values are positive (Table 1). 
Electronic absorption spectroscopy 
The electronic absorption spectra of Co(II)-loaded PfMetAP-II 
and EcMetAP-I were recorded in the absence and presence of A-
310840 and A-311263 (Figs. 2, ,3)3) and the absorption due to 
apoenzyme was subtracted in each case. The absorption spectra of the 
uncomplexed wild-type Co(II)-loaded PfMetAP-II and EcMetAP-I 
enzymes were identical to those previously reported.23,28 Upon the 
addition of 1 equiv of A-310840 to both Co(II)-loaded PfMetAP-II and 
Co(II)-loaded EcMetAP-I, the molar absorptivities increased by 
approximately140 M−1 cm−1. The observed increase in absorbance at 
approximately 550 nm is similar in magnitude to that observed at 400 
nm, raising the possibility that this increase may be to do to an 
underlying charge-transfer or π → π* transition with λ < 400 nm, 
rather than a change in absorptivity of the d–d bands from Co(II). 
Upon closer inspection, the λmax values of the absorption maxima show 
small blueshifts compared with those of the wild-type enzymes, 
indicating that A-310840 directly interacts with the Co(II) active sites 
of both EcMetAP-I and PfMetAP-II. Interestingly, the addition of 1 
equiv of A-311263 to both Co(II)-loaded PfMetAP-II and Co(II)-loaded 
EcMetAP-I also perturbs the visible absorption spectra of Co(II)-loaded 
EcMetAP-I and PfMetAP-II, but in a way markedly different from that 
of A-310840. The maximum molar absorptivity decreases upon the 
addition of A-311263 to Co(II)-loaded PfMetAP-II by approximately 50 
M−1 cm−1, but the observed λmax value remains unaffected. The 
maximum molar absorptivity does not change upon the addition of A-
311263 to Co(II)-loaded EcMetAP-I (approximately 90 M−1 cm−1); 
however, the λmax value shifts from 580 to 560 nm. 
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Fig. 2. UV–vis spectrum of wild-type [CoCo(PfMetAP-II)] (dashed line), A-310840 
bound to [CoCo(PfMetAP-II)] (solid line), and A-311263 bound to [CoCo(PfMetAP-II)] 
(dotted line) in 25 mM N-(2-hydroxyethyl)piperazine-N′-ethanesulfonic acid (HEPES) 
buffer, pH 7.5, and 150 mM KCl. The absorption due to apoenzyme was subtracted in 
each case. PfMetAP-II is type-II methionine aminopeptidase (MetAP) from Pyrococcus 
furiosus 
 
 
Fig. 3. UV–vis spectrum of wild-type [CoCo(EcMetAP-I)] (dashed line), A-310840 
bound to [CoCo(EcMetAP-I)] (solid line), and A-311263 bound to [CoCo(EcMetAP-I)] 
(solid line) in 25 mM HEPES buffer, pH 7.5, and 150 mM KCl. The absorption due to 
apoenzyme was subtracted in each case. EcMetAP-I is type-II MetAP from Escherichia 
coli 
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EPR spectra of A-310840 and A-311263 bound to 
Co(II)- and Mn(II)-loaded PfMetAP-II and EcMetAP-I 
EPR spectra for both Co(II)-loaded PfMetAP-II and Co(II)-loaded 
EcMetAP-I have been reported previously.23 These spectra contain 
broad features and exhibit no resolvable 59Co hyperfine splitting, 
presumably owing to extensive strains in g and/or zero-field-splitting 
parameters. The spectra observed for Co(II)-loaded PfMetAP-II and 
EcMetAP-I upon the addition of A-310840 or A-311263 are shown in 
Fig. 4 along with computer simulations. Spin Hamiltonian parameters 
derived from these simulations are provided in Table 2. In each case, 
the EPR spectra of the inhibited forms of Co(II)-loaded PfMetAP-II and 
EcMetAP-I are very similar to the spectrum from the corresponding 
unligated enzyme. The observed signals are dominated by an 
essentially axial component with E/D ∼ 0.09. For Co(II)-loaded 
EcMetAP-I + A-310840 (Fig. 4, spectrum B) and Co(II)-loaded 
PfMetAP-II + A-311263 (Fig. 4, spectrum C), a low-field eight-line 
hyperfine pattern was resolved, indicating the presence of a second, 
minor species with markedly lower geff strain. This signal may also be 
present in the spectrum of Co(II)-loaded PfMetAP-II + A-310840 (Fig. 
4, spectrum D), but at very low concentrations, and was not observed 
for Co(II)-loaded EcMetAP-I + A-311263 (Fig. 4, spectrum A). In the 
EPR spectrum of Co(II)-loaded EcMetAP-I bound by A-310840 (Fig. 4, 
spectrum B), another feature associated with this second, minor 
species is observed at an inflection around 1,900 G. On the basis of 
this feature, gx,y and hence E/D could be reasonably estimated by 
simulation, resulting in an MS = ±½ species with E/D = 0.22. These 
parameters are typical for five-coordinate Co(II) centers bound within 
a rigid coordination sphere.31-33 For Co(II)-loaded PfMetAP-II + A-
311263 (Fig. 4, spectrum C), only the hyperfine pattern could be 
distinguished, at lower field than that observed for Co(II)-loaded 
EcMetAP-I + A-310840. The actual values of gx,y and E/D for this minor 
species are dependent on the identity of the ground-state doublet and 
therefore cannot be determined from these data. 
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Fig. 4. EPR spectra of MetAP species containing Co(II). In A–D, the upper spectrum is the experimental 
spectrum and the lower spectrum is a computer simulation: [CoCo(EcMetAP-I)] + A-311263 (A); 
[CoCo(EcMetAP-I)] + A-310840 (B); [CoCo(PfMetAP-II)] + A-311263 (C); [CoCo(PfMetAP-II)] + A-310840 (D). 
Trace E is of naked [CoCo(PfMetAP-II)]]. Experimental spectra were recorded at 7 K, 0.2 mW (A–C); 9 K, 0.2 
mW (D), and 5 K, 0.2 mW (E). Spin Hamiltonian parameters for the simulations are given in Table 2 
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Table 2. Spin Hamiltonian parameters for the dominant axial and minor 
rhombic species obtained from the computer simulation of EPR spectra of 
Co(II)-loaded EcMetAP-I and PfMetAP-II in the presence of either A-310840 
or A-311263 
Wild-type enzymes Axial 
 
Rhombic 
 
 g(x, y) g(z) E/D g(x, y) [A(y) (10−3 cm−1)] g(z) E/D 
A-310840 binding to wild-type enzymes 
[CoCo(PfMetAP-II)] 2.21 2.09 0.09 ND ND ND 
[CoCo(EcMetAP-I)] 2.316 2.650 0.095 2.52 [8.6] 2.56 0.22 
A-311263 binding to wild-type enzymes 
[CoCo(PfMetAP-II)] 2.21 2.09 0.09 2.5−2.9 [10.6] ND ND 
[CoCo(EcMetAP-I)] 2.316 2.650 0.095 ND ND ND 
ND not determined 
In addition to the S = 3/2 signals observed for each of the 
Co(II)-loaded MetAP-inhibited complexes, weak signals were observed 
between geff = 10 and 12 in parallel mode (not shown) for Co(II)-
loaded PfMetAP-II and EcMetAP-I bound by A-311263 and Co(II)-
loaded EcMetAP-I + A-310840. These data are consistent with S′ = 2 
and/or S′ = 3 transitions from an S = 0, 1, 2, 3 spin ladder due to spin 
coupling between two S = 3/2 Co(II) ions. While quantification of 
broad, weak integer spin signals of indeterminate S′ origin and with 
absorption into zero field is unreliable, integration of the S = 3/2 
components based on simulation of the observed spectra suggested 
that approximately 85 ± 10% of the Co(II) ions are accountable for by 
the observed S = 3/2 species. The observed integer-spin signals are 
particularly pronounced for Co(II)-loaded PfMetAP-II + A-311263, and 
the same integer-spin transitions are likely due to the EPR absorption 
at very low field (0−500 G) observed in normal-mode EPR (Fig. 4, 
spectrum C; a small amount of such a signal was included in the 
simulation but parameters are not given as no attempt was made to 
fully characterize or quantify this signal). It is unlikely that these 
signals are dependent upon the inhibitor as similar low-field signals are 
observed for uncomplexed Co(II)-loaded PfMetAP-II (Fig. 4, spectrum 
E) and EcMetAP-I enzymes at high pH. Indeed, the lack of such signals 
from Co(II)-loaded PfMetAP-II + A-310840 may be of more 
significance. 
The EPR spectra of Mn(II)-loaded EcMetAP-I and PfMetAP-II 
complexed with either A-310840 or A-311263 are presented in Fig. 5. 
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When Mn(II)-loaded EcMetAP-I and PfMetAP-II were incubated with A-
310840, both enzymes displayed signals superficially similar to those 
of the corresponding wild-type enzymes. Characteristic central six-line 
patterns with approximately 90 G splitting and Curie law temperature 
dependence are observed, as well as additional features that 
demonstrate Boltzmann temperature dependence and an 
approximately 45 G splitting.25,26 The central six-line patterns observed 
for Mn(II)-loaded EcMetAP-I and PfMetAP-II bound by A-310840 are 
somewhat lower in intensity compared to those of wild-type forms of 
the enzymes, but the individual lines are better resolved. However, the 
resonance positions of the transitions in the 3,000−3,800-G region of 
the spectra are indistinguishable (Fig. 5, spectra F, H). Both sets of 
spectra provide other features with Boltzmann temperature 
dependence that exhibit approximately 45 G splitting, characteristic of 
dinuclear Mn(II) centers (Fig. 5, spectra I, K, L, N). 
 
Fig. 5. EPR spectra from MetAP containing Mn(II). Traces A–E are 6,000-G (600-mT) 
experimental scans. Traces F, G, and H and I, J, and K are expanded views of selected 
regions of A, B, and C, respectively. Traces L, M, and N are derivatives of traces I, J, 
and K, respectively. The traces correspond to [MnMn(EcMetAP-I)] + A-310840 (A, F, I, 
L), [MnMn(EcMetAP-I)] + A-311263 (B, G, J, M), [MnMn(Pf(MetAP-II)] + A-310480 (C, 
H, K, N), and [MnMn (Pf(MetAP-II)] + A-311263 (D). Trace E is a computer simulation 
of trace D assuming S = 5/2, g = 2.0, AI = 5/2 8.8 × 10−3 cm−1, D = 86 × 10−3 cm−1, 
σD = 7 × 10−3 cm−1, E/D = 0, and σE/D = 0.14. Experimental spectra were recorded 
at 30 K, 0.2 mW (A–C, F–H, I–K) or at 40 K, 0.2 mW (D) 
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In contrast, the addition of A-311263 to Mn(II)-loaded EcMetAP-
I and PfMetAP-II provided EPR spectra that are distinctly different from 
those of wild-type Mn(II)-loaded enzymes. The spectrum of Mn(II)-
loaded EcMetAP-I + A-311263 contained a central six-line pattern (Fig. 
5, spectrum G) indistinguishable from the patterns of the A-310840 
complexes and wild-type enzymes. However, this signal did not exhibit 
the Boltzmann-temperature-dependent “wings” at 2,200−2,600 G with 
approximately 45 G splittings that are characteristic of Mn(II)–Mn(II) 
spin–spin coupling (Fig. 5, spectra J, L). More dramatic differences 
were seen in the spectrum of Mn(II)-loaded PfMetAP-II + A-311263 
(Fig. 5, spectrum D). A very complex spectrum was observed that had 
intense features across the field range 0−6,000 G. The form of this 
spectrum was essentially invariant from 5 to 40 K and exhibited Curie 
law temperature dependence, suggesting that the features are due to 
isolated S = 5/2 Mn(II) ions. Indeed, this signal could be well 
simulated assuming a single Mn(II) species with spin Hamiltonian 
parameters S = 5/2, g = 2.0, AI = 5/2 = 8.8 × 10−3 cm−1, D = 86 × 10−3 
cm−1, σD = 7 × 10−3 cm−1, E/D = 0, and σE/D = 0.14 (Fig. 5, 
spectrum E). 
Discussion 
Type-II MetAPs have been identified as the molecular target for 
antiangiogenesis agents such as fumagillin and its derivatives,3,34 
whereas type-I MetAPs have been suggested to be potential 
antibacterial and/or antifungal targets.35,36 Therefore, developing a 
detailed understanding of how potential small molecule drug 
candidates interact with the active sites of MetAPs will facilitate the 
rational design of new, potent MetAP inhibitors with improved in vivo 
stability and cytotoxicity.37 As one might expect, most of the 
information regarding the binding of MetAP inhibitors has come from 
the inspection of X-ray crystal structures.22,38,39 Although such 
crystallo-graphic information is extremely valuable, it represents a 
static view that may not be representative of a dynamic enzyme. Thus, 
detailed solution characterization of MetAP drug candidates is critically 
important in the design and development of new drugs. Herein we 
have investigated the binding affinities and the spectroscopic 
properties of two inhibitors of PfMetAP-II and EcMetAP-I, namely, a 
triazole-containing inhibitor 3-((2-naphthylmethyl)sulfanyl)-4H-1,2,4-
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triazole (A-310840) and a bestatin-like inhibitor ((2RS,3R)-3-amino-2-
hydroxy-5-ethylthio)pentanoyl-((S)-(−)-(1-naphthyl)ethyl)amide (A-
311263).25 
Examination of the inhibition patterns of both Co(II)-and Mn(II)-
loaded EcMetAP-I and PfMetAP-II in the presence of A-310840 and A-
311263 revealed that they are both moderately strong competitive 
inhibitors. A-310840 preferentially inhibits Co(II)-loaded EcMetAP-I 
and PfMetAP-II enzymes over the Mn(II)-loaded enzymes, whereas A-
311263 shows little or no metal ion selectivity for either type-I or 
type-II enzymes. The observed Ki values follow the same trend as the 
IC50 values obtained for EcMetAP-I, PfMetAP-II, and HsMetAP-II except 
that the IC50 values are substantially weaker for the two bacterial 
enzymes compared with the human type-II enzyme.25 For competitive 
inhibitors, the observed Ki value is equal to the dissociation constant 
(Kd); therefore, ITC not only provides the opportunity to compare 
experimentally derived Kd values with Ki values, but also to obtain 
thermodynamic parameters for inhibitor binding to both the PfMetAP-II 
and EcMetAP-I enzymes in a single experiment. The Kd values derived 
from ITC are in reasonable agreement with the kinetically derived Ki 
values (Table 1). The observed enthalpies (ΔH) for the binding of A-
310840 and A-311263 to Mn(II)-loaded PfMetAP-II and EcMetAP-I are 
negative. However, both A-310840 and A-311263 exhibited positive 
ΔH values for binding to Co(II)-loaded EcMetAP-I but negative ΔH 
values for binding to Co(II)-loaded PfMetAP-II. These data exemplify 
the active-site differences between type-I and type-II MetAPs and 
indicate that Mn(II)-loaded MetAPs more favorably bind these 
inhibitors, and possibly substrates. Interesting, the entropic factor 
(TΔS) follows an opposite trend, with inhibitor binding to the Co(II)-
loaded enzymes being more entropically favored than inhibitor binding 
to Mn(II)-loaded MetAPs. Combination of the observed ΔH and TΔS 
values for A-310840 and A-311263 binding to both the Co(II)-loaded 
and the Mn(II)-loaded PfMetAP-II and EcMetAP-I enzymes are all 
negative, indicating that inhibitor binding is spontaneous. However, 
the observed ΔG values favor inhibitor binding to the Co(II)-loaded 
PfMetAP-II and EcMetAP-I enzymes over the Mn(II)-loaded forms by 
nearly 30%. 
To gain some structural insight into how A-310840 and A-
311263 bind to both type-I and type-II MetAPs in the presence of 
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either Mn(II) or Co(II), electronic absorption and EPR spectra were 
recorded in the presence of each inhibitor. The observed changes in 
electronic absorption spectra of the Co(II)-loaded forms of PfMetAP-II 
and EcMetAP-I upon A-310840 and A-311263 binding indicate that 
each ligand interacts with the active-site Co(II) ions. Moreover, the 
observed molar absorptivities upon A-310840 binding to Co(II)-loaded 
EcMetAP-I and PfMetAP-II suggest that the active-site Co(II) ions are 
five-coordinate, while A-311263 binding provides a Co(II) environment 
that is five- or six-coordinate.40 Similarly, the observed EPR spectra of 
the Co(II)-loaded EcMetAP-I and PfMetAP-II enzymes in the presence 
of A-311263 are due to transitions in the MS = ±½ Kramers doublets 
and arise from either five- or six-coordinate Co(II) ions The broad, 
featureless EPR signals from the dominant axial components of the 
spectra indicate significant structural microheterogeneity in each case; 
thus, there is a great deal of flexibility in the ligand environment, 
perhaps related to coordination by water. For Co(II)-loaded EcMetAP-I 
and PfMetAP-II enzymes in the presence of A-310840 a minor species, 
in some cases with well-resolved hyperfine splitting and significant 
rhombic distortion of the axial zero-field splitting, is observed, 
suggesting an alternative geometry with a rigid coordination 
environment and likely five-coordinate geometry.41,42 Similar species 
observed in the EPR spectra of Co(II)-substituted forms of the 
aminopeptidase from Aeromonas proteolytica have been shown to be 
pH-dependent.41,42 
For a small percentage (less than 15%) of Co(II) ions bound to 
either the EcMetAP-I or PfMetAP-II enzymes in the presence of A-
311263 and the Co(II)-loaded form of EcMetAP-I bound by A-310840, 
a weak integer spin signal in the parallel mode is observed. However, 
for Co(II)-loaded PfMetAP-II bound by A-310840, no integer spin 
signal is observed. EPR studies on Co(II)-loaded EcMetAP-I revealed 
that at pH 7.5 there is no significant spin coupling between the two 
Co(II) ions, though a small proportion (approximately 5%) of the 
sample exhibited detectable spin–spin interactions at pH values above 
9.6.23 Therefore, the integer spin signals observed for the EcMetAPI-
inhibited enzymes are likely due to inhibitor binding since no spin–spin 
interactions are observed in the absence of inhibitor. Conversely, the 
uncomplexed form of Co(II)-loaded PfMetAP-II exhibits detectable 
(approximately 15%) spin–spin interactions at pH 7.5. Thus, the 
observed integer spin signal for Co(II)-loaded PfMetAP-II bound by A-
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311263 is identical to that for the uncomplexed enzyme, suggesting 
that the binding of A-311263 does not provide a single atom bridge 
between the two Co(II) ions bound in the active site. However, the 
lack of an observable integer spin signal when A-310840 is complexed 
with Co(II)-loaded PfMetAP-II suggests that A-310840 may modulate 
anti-ferromagnetic coupling via a diazine bridge. Such a coupling 
interaction is consistent with the limited number of diazine-bridged 
dinuclear Co(II) model complexes.43-45 The lack of intense parallel-
mode signals is likely due to the weak Kd values observed for the 
second Co(II) binding event (0.35 and 2.5 mM for PfMetAP-II and 
EcMetAP-I, respectively), which provides enzyme samples containing a 
mixture of both mononuclear and dinuclear Co(II) centers with the 
majority of sites in the mononuclear state.23,28 For dinuclear Co(II) 
species, it appears that the binding of either A-311263 or A-310840 
modulates the exchange interaction between the Co(II) ions by 
altering the precise nature of the electronic wavefunction overlap 
network (i.e., the bonding network) between these ions. 
Both PfMetAP-II and EcMetAP-I exhibit distinct binding constants 
for two Mn(II) ions, and the higher of these, Kd2, dictates that distinct 
MetAP species containing either one or two Mn(II) ions will be present 
in samples prepared even at millimolar concentrations.22,46,47 The dinu-
clear forms have been shown to contain two Mn(II) ions in close 
proximity and, for both PfMetAP-II and EcMetAP-I, features in the EPR 
spectra have been identified that clearly show spin–spin interaction 
between the two Mn(II) ions.43-46 As expected, EPR spectra obtained 
for the Mn(II)-loaded forms of both PfMetAP-II and EcMetAP-I in the 
presence of either A-311263 or A-310840 indicate the presence of 
magnetically isolated S = 5/2 Mn(II) ions coordinated by oxygen- and 
nitrogen-containing ligands.46 The S = 5/2 components of the spectra 
with A-310840 were indistinguishable from those of the corresponding 
resting enzymes. The EPR spectra of PfMetAP-II and EcMetAP-I 
incubated with A-310840 exhibited features that are characteristic of 
spin–spin coupling between the Mn(II) ions; again, these features 
were very similar to those exhibited by the corresponding resting 
enzymes. The lack of significant perturbation of the electronic 
structure of the monomanganese and dimanganese species of these 
enzymes by A-310840 is likely related to the poor efficacy of this 
inhibitor for the manganese forms of PfMetAP-II and EcMetAP-I. 
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Significant differences in the electronic structures of the Mn(II) 
complements of PfMetAP-II and EcMetAP-I were elicited by incubation 
with A-311263 in contrast to incubation with A-310840. In the case of 
Mn(II)-loaded EcMetAP-I + A-311263, no signals or temperature-
dependent features corresponding to spin-coupled Mn(II)–Mn(II) were 
observed between 5 and 50 K. This observation suggested the loss of 
any spin–spin interaction. The loss of the S′ = 1, 2,..., 5 signals would 
be expected to result in an increase in the S = 5/2 signal intensity due 
to the newly separated Mn(II) ions; the loss of the dipolar component 
of the coupling would, of course, entail physical separation of the two 
Mn(II) ions. Intriguingly, no significant enhancement of the central six-
line pattern signal intensity was observed. Therefore, it is unclear 
whether no inter-Mn(II) interaction exists or whether the interaction is 
present but unobservable. An unusually high spin-coupling constant 
(|J| >> 35 cm−1) would prevent the population of S′ > 0 levels owing 
to zero-field splitting within the non-Kramers doublets of populated S′ 
> 0 states (Δ > 0.3 cm−1), which results from broadening by large 
increases in the values and/or distributions of the individual Mn(II) 
zero-field-splitting parameters. Alternatively, a relaxation-dependent 
phenomenon may be in play. Regardless, the inter-Mn(II) interaction 
in Mn(II)-loaded EcMetAP-I is significantly perturbed, either abolished 
or greatly enhanced, by A-311286. 
The EPR spectrum obtained for Mn(II)-loaded PfMetAP-II + A-
311286 looked completely different from any other EPR signal 
observed for a MetAP species but was very similar to the EPR signal 
observed for the argE-encoded N-acetyl-l-ornithine deacetylase from 
E. coli.47 Despite the complexity of this signal, it was simulated as a 
single S = 5/2 Mn(II) environment, consistent with its temperature 
dependence. The lack of an intense central six-line pattern is due to a 
distribution in E/D; although the system is nominally axially symmetric 
with a mean E/D = 0 assumed for the sample, the distribution results 
in a significant proportion of the molecules in the sample exhibiting 
E/D ≠ 0. Thus, it appears that a rhombic distortion is introduced into 
the electronic symmetries of the Mn(II) ions bound to PfMetAP-II upon 
complexation with A-311286. Similar to Mn(II)-loaded EcMetAP-I, no 
evidence is observed for inter-Mn(II) spin coupling in the EPR 
spectrum obtained for Mn(II)-loaded PfMetAP-II + A-311286, further 
supporting the contention that the active site is significantly perturbed 
by A-311286. 
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The X-ray crystal structure of A-311263 bound to HsMetAP-II 
revealed the presence of a μ-alkoxide bridge.48 In addition, the X-ray 
crystal structure of a related purported substrate-analog inhibitor 
(3R)-amino-(2S) hydroxyheptanoyl-l-Ala-l-Leu-l-Val-l-Phe-OMe (SK-V-
126) bound to EcMetAP-I has been reported.18 In this structure, the N-
terminal amine coordinated Co2, the keto oxygen (analogous to the 
carbonyl carbon in a terminal peptide bond) is ligated to Co1, and the 
(2S)-hydroxyl group displaces the bridging water/hydroxide ion.1,18 
Taken together with the EPR data, which primarily contain data for 
mononuclear enzyme species, this suggests the alkoxide moiety 
displaces the water (hydroxide) oxygen atom and is terminal on M1, 
while the N-terminal amine nitrogen of the inhibitor is bound by the 
carboxylate groups making out the purported second metal binding.22 
Inspection of the X-ray crystal structure of the dicobalt(II) form of 
type-I MetAP from S. aureus complexed with a 1,2,4-triazole-based 
inhibitor and the crystal structure of a 1,2,3-triazole-based inhibitor 
bound to the dicobalt(II) form of HsMetAP-II reveals that a common 
feature for the triazole derivative in enzyme recognition is the 
interaction of the nitrogen atoms in positions 1 and 2 with the 
dicobalt(II) center such that their N–N bond is nearly collinear with the 
metal–metal vector in the dinuclear site.49-51 
Combination of EPR and crystallographic data suggests that 
when two metal ions are bound to MetAPs, A-310840 binds via a 
diazine bridge (Fig. 6). On the other hand, when only one Co(II) ion is 
bound in a MetAP active site, binding of A-310840 clearly results in a 
more rigid five-coordinate environment. Conversely, the addition of A-
310840 does not markedly perturb the EPR spectra of either Mn(II)-
loaded PfMetAP-II or Mn(II)-loaded EcMetAP-I. These data indicate 
nonbinding or a very weak binding interaction of the triazole ligand 
with the Mn(II) ions bound in the MetAP active sites. Therefore, the 
specificity of A-310840 for Co(II) over Mn(II) is likely due to Co(II)'s 
preference for softer donor ligands (nitrogen) over harder donor 
ligands (oxygen).52,53 However, this explanation does not tell the entire 
story. Since MetAPs are likely a mixture of mononuclear and dinuclear 
enzymes under physiological conditions54,55 and the putative partially 
empty, second metal binding site is carboxylate-rich, the lone pair of 
electrons on the N2 atom of the triazole ligand will be repelled by the 
negative charge associated with the carboxylate groups in this site. 
Alternatively, the N-terminal amine moiety of A-311263 will form a 
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zwitterionic interaction with this carboylate site, resulting in an 
additional binding interaction over the A-310840 molecule (Fig. 7). 
This hypothesis is consistent with the observed thermodynamic 
parameters for both A-310840 and A-311263 binding to Co(II)- and 
Mn(II)-loaded PfMetAP-II or EcMetAP-I, particularly in the decrease in 
ΔG observed for A-310840 binding to Mn(II)-loaded MetAPs compared 
with Co(II)-loaded enzymes. 
 
Fig. 6. Proposed scheme for binding of A-310840 to the active sites of both Co(II)- 
and Mn(II)-loaded EcMetAP-I (residue numbering) and PfMetAP-II 
 
Fig. 7. Proposed scheme for binding of inhibitor A-311263 to the active site of both 
Co(II)- and Mn(II)-loaded EcMetAP-I (residue numbering) and PfMetAP-II 
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